Dr. Reddy's Laboratories has launched the first generic version of Bayer/Alcon’s Ciprodex (ciprofloxacin/dexamethasone) 0.3%/0.1% otic suspension in the US, as rival Endo International suffered a “major” setback for its filing from the US Food and Drug Administration.
Dr Reddy’s Pounces On US Ciprodex Generic As Endo Stumbles
Follows Expiry Of Key Ciprodex Patents
Dr Reddy’s Laboratories has leapfrogged Endo by launching a generic version of of Bayer/Alcon’s Ciprodex (ciprofloxacin/dexamethasone) 0.3%/0.1% otic suspension, as the US firm was stung with a major rejection by the US FDA.
